Author: Carly Behm

Orthopedic devicemaker Conformis posted first-quarter revenue of $15.6 million and an 18 percent increase in hip sales. It also saw an increased net loss.

Ortho Regenerative Technologies received a patent related to its Ortho-R soft tissue repair platform.

Camber Spine's latest patent and eight more updates from spine and orthopedic devicemakers in the last week:

Data for a two-year trial of Stryker's InSpace subacromial balloon found the device was a viable option for patients with massive irreparable rotator cuff tears.

SeaSpine's first-quarter sales grew across its spinal implants and orthobiologics, and the company named new leadership.

Wenzel Spine appointed William Wilson as CEO almost two months after the devicemaker's former CEO died.

Genesys Spine is partnering with Pria Healthcare to improve patient coverage for its sacroiliac joint fusion products.

Orthofix is renewing its partnership with MTF Biologics for marketing and development of products.

The American Academy of Orthopaedic Surgeons formed a $1 million grant program for diversity, equity and access in orthopedics.

Orthopedics remains one of the highest-paid physician specialties, but how does it compare to CEOs in the field?